Bukong, T. N., Iracheta-Vellve, A., Saha, B., Ambade, A., Satishchandran, A., Gyongyosi, B., . . . Szabo, G. (2016). Inhibition of spleen tyrosine kinase activation ameliorates inflammation, cell death, and steatosis in alcoholic liver disease. Hepatology.
Citación estilo ChicagoBukong, Terence N., et al. "Inhibition of Spleen Tyrosine Kinase Activation Ameliorates Inflammation, Cell Death, and Steatosis in Alcoholic Liver Disease." Hepatology 2016.
Cita MLABukong, Terence N., et al. "Inhibition of Spleen Tyrosine Kinase Activation Ameliorates Inflammation, Cell Death, and Steatosis in Alcoholic Liver Disease." Hepatology 2016.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.